European Society for Medical Oncology (ESMO)

ESMO Sarcoma and Rare Cancers 2024: Robin L. Jones on why you should attend the Congress

ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trial

Why young oncologists should attend ESMO Asia 2024 - Prof. Lim

ESMO Immuno-Oncology 2024 Congress Experts in the field invite you to share your research.

Claudia Cardone & Andreas Koulouris on how the ESMO Academy helps prepare for the ESMO Examination

Why you should submit your abstract for MAP 2024

#ESMOGynae24

ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.

MAP 2024: shaping the future of precision oncology

ESMO Immuno-Oncology 2024: Experts in different tumour types explain the importance of this congress

ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region

ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition

ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabelle and I. Svane invite you to attend

Why you should attend ESMO Asia 2024 - Prof. Cervantes

ESMO Breast Cancer 2025: Invitation from Scientific Committee Co-Chairs

ESMO Virtual Mentorship Programme

World renowned experts on why you should attend MAP 2024

Recommendations for the use of NGS in patients with metastatic cancer

ESMO Recommendations on clinical reporting of genomics test results for solid cancers

ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity

MAP 2024: why you should attend this global congress in precision oncology

ESMO 2024: Join your international community in Barcelona, or Online

Precision Medicine in Prostate Cancer

ESMO Gynaecological Cancers Congress 2024 Members of the Scientific Committee invite you to register

ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat

Unlock your future: Why Young Oncologists should attend MAP 2024

How to manage toxicities from Immune Checkpoint Inhibitors?

#ESMO24

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

BRAF Mutations Across Cancers

Is the COVID-19 pandemic exacerbating gender inequalities in oncology?

ESMO Women for Oncology Forum 2022 on Gender Equity in Oncology: Challenges & Opportunities

#ESMO23

Discrepancies in Cancer Pain Treatment Across the Globe

Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer

Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021

What are the highlights of the MAP 2021 pre-congress educational workshop? - Prof. Fabrice André

ASCO 2023 Highlights on the MIRASOL trial in PT-resistant adv. high-grade epithelial Ovarian Cancer

ESMO Immuno-Oncology Congress 2021: Prof. Kevin Harrington tells you what to expect from this event

Patient-derived xenograft models

ESMO Asia 2023: A. Cervantes on why young oncologists should attend this influential oncology event

ESMO Congress 2023: Register for this influential oncology platform

ESMO 2020 Expert Video Report on rare sarcomas histotypes

ESMO Asia 2023: Sanjay Popat on why young oncologists should attend this influential oncology event

ESMO 2020 Expert Video Report on precision medicine in prostate cancer

ESMO Sarcoma and Rare Cancers 2024: Robin L. Jones on why you should attend the Congress

Mechanisms of TKI resistance

ESMO Asia 2023: L. Albiges on programme highlights from this influential Asia-Pacific oncology event